CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Revenue
Operating expenses:
General and administrative (including stock-based compensation)	3,072,163	2,348,324
Depreciation	1,645	1,161
Research and development (including stock-based compensation)	82,759	200,691
Total operating expenses	3,156,567	2,550,176
Loss from operations	(3,156,567)	(2,550,176)
Other (income) expense:
Interest income	(5,836)	(5,625)
Interest expense	38,384	301,659
Gain on sale of domain		(902,490)
Gain on legal dissolution of subsidiary		(10,234,501)
Total other expense	32,548	(10,840,957)
Net income (loss)	(3,189,115)	8,290,781
Net loss attributable to the noncontrolling interest		1,544
Net income (loss) applicable to Bion's common stockholders	$ (3,189,115)	$ 8,292,325